BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30068389)

  • 1. RNA binding proteins co-localize with small tau inclusions in tauopathy.
    Maziuk BF; Apicco DJ; Cruz AL; Jiang L; Ash PEA; da Rocha EL; Zhang C; Yu WH; Leszyk J; Abisambra JF; Li H; Wolozin B
    Acta Neuropathol Commun; 2018 Aug; 6(1):71. PubMed ID: 30068389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
    Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.
    Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.
    Polanco JC; Scicluna BJ; Hill AF; Götz J
    J Biol Chem; 2016 Jun; 291(24):12445-12466. PubMed ID: 27030011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies.
    Vanderweyde T; Yu H; Varnum M; Liu-Yesucevitz L; Citro A; Ikezu T; Duff K; Wolozin B
    J Neurosci; 2012 Jun; 32(24):8270-83. PubMed ID: 22699908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia.
    Planel E; Bretteville A; Liu L; Virag L; Du AL; Yu WH; Dickson DW; Whittington RA; Duff KE
    FASEB J; 2009 Aug; 23(8):2595-604. PubMed ID: 19279139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo.
    Apicco DJ; Ash PEA; Maziuk B; LeBlang C; Medalla M; Al Abdullatif A; Ferragud A; Botelho E; Ballance HI; Dhawan U; Boudeau S; Cruz AL; Kashy D; Wong A; Goldberg LR; Yazdani N; Zhang C; Ung CY; Tripodis Y; Kanaan NM; Ikezu T; Cottone P; Leszyk J; Li H; Luebke J; Bryant CD; Wolozin B
    Nat Neurosci; 2018 Jan; 21(1):72-80. PubMed ID: 29273772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau interactome and RNA binding proteins in neurodegenerative diseases.
    Kavanagh T; Halder A; Drummond E
    Mol Neurodegener; 2022 Oct; 17(1):66. PubMed ID: 36253823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated tau interactome in the human Alzheimer's disease brain.
    Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
    Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
    Yoshida M
    Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.
    Spires-Jones TL; Friedman T; Pitstick R; Polydoro M; Roe A; Carlson GA; Hyman BT
    Neurosci Lett; 2014 Mar; 562():63-8. PubMed ID: 24462887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
    Wilhelmus MM; de Jager M; Rozemuller AJ; Brevé J; Bol JG; Eckert RL; Drukarch B
    J Pathol; 2012 Jan; 226(1):132-42. PubMed ID: 22009441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A seeding based cellular assay of tauopathy.
    Xu Y; Martini-Stoica H; Zheng H
    Mol Neurodegener; 2016 Apr; 11():32. PubMed ID: 27112488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity.
    Ahmed Z; Cooper J; Murray TK; Garn K; McNaughton E; Clarke H; Parhizkar S; Ward MA; Cavallini A; Jackson S; Bose S; Clavaguera F; Tolnay M; Lavenir I; Goedert M; Hutton ML; O'Neill MJ
    Acta Neuropathol; 2014 May; 127(5):667-83. PubMed ID: 24531916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased G3BP2-Tau interaction in tauopathies is a natural defense against Tau aggregation.
    Wang C; Terrigno M; Li J; Distler T; Pandya NJ; Ebeling M; Tyanova S; Hoozemans JJM; Dijkstra AA; Fuchs L; Xiang S; Bonni A; Grüninger F; Jagasia R
    Neuron; 2023 Sep; 111(17):2660-2674.e9. PubMed ID: 37385246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.